eFFECTOR Therapeutics, Inc. ( EFTR) - Stock Earnings
EFTR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 17, 2026, midnight | — / — | — | — / — | — |
EFTR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -10.0 million USD | — USD |
| 2023Q2 | -8.4 million USD | — USD |
| 2023Q3 | -8.3 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
EFTR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 15.8 million USD | 1.4 million USD |
| 2022 | -12.9 million USD | 3.6 million USD |
| 2023 | -35.9 million USD | — USD |
| 2026 Est. | — | — |
EFTR
Price: $0
52 week price:
Earnings Per Share: -12.57 USD
P/E Ratio: -0.65
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 547000
Market Capitalization: 941